Market requirements · GR
Greece
EOF issued a public warning in July 2026, and related reporting names specific compounds. Regulatory attention in this market is high.
Buyers in this market search for: peptidia hondriki, erevnitika peptidia.
| Tell us the compounds you need for Greece. | Ask about Greece |
The regime
How compounds are classified in Greece
| Governing law and regulator | Greece's medicines regulator is EOF (Ethnikos Organismos Farmakon / National Organization for Medicines). EOF's stated position is that legal medicine distribution happens exclusively through licensed pharmacies. |
|---|---|
| Direct regulator statement, July 2026 | EOF issued a public warning against products marketed as intravenous or IV-vitamin food supplements, stating any substance intended for intravenous infusion falls under medicines-licensing law, that unlicensed production or circulation is illegal, and that safety, quality and efficacy have not been evaluated. |
| Named compounds | A related August 2026 piece reporting on EOF's position names BPC-157, CJC-1295, Ipamorelin, Epitalon, MOTS-c and TB-500 as not approved for human administration and still at research stage; we flag this specific compound list as reported second-hand by a health-news blog, not a verbatim EOF quote, though the underlying prohibition position is corroborated by primary-source-adjacent EOF coverage. |
| Prescription-only position | EOF's position, per the warning, is that any substance affecting the body via infusion or injection requires a marketing authorisation and licensed-pharmacy distribution; there is no carve-out for 'research' labelling. |
| Enforcement posture | Beyond the July 2026 warning, Greek mainstream media has separately covered social-media influencers promoting peptides with extravagant claims, quoting experts on contamination and dosing risk, indicating active media and public scrutiny alongside the regulator warning. |
| Already supplying Greece? Send the compounds and volumes you buy today and we will quote against them. | Send your list |
Your obligations
What a buyer in Greece needs settled
- Assume the six EOF-referenced compounds (BPC-157, CJC-1295, Ipamorelin, Epitalon, MOTS-c, TB-500) is explicitly flagged by Greek authorities or press and require the most conservative claims language for this market.
- Do not market or ship anything framed as an intravenous or injectable preparation without a marketing authorisation and licensed-pharmacy channel.
- Confirm any compound-specific claim against a primary EOF source before publishing, since the compound list itself comes from a secondary health-news summary.
- Expect a higher enforcement-attention environment in Greece than most other markets researched; budget compliance review accordingly.
We will ask about this at enquiry. We check the authorisations your activity requires before quoting, and we confirm the position per compound rather than for the market as a whole.
Sources
Check this yourself
Every position above traces to a dated public document. The authority, the document, the date and the link are below.
| Authority and document | Date | Link |
|---|---|---|
| EOF (via Protothema) EOF proeidopoiisi gia paranomi proothisi kai horigisi endoflevion therapeion os sympliromaton diatrofis | July 2026 | www.protothema.gr/greece/article/1847724/eof-proeidopoiisi... |
| LiFO EOF proeidopoiisi gia endoflebies therapeies pou proothoyntai os sympliromata diatrofis | July 2026 | www.lifo.gr/now/greece/eof-proeidopoiisi-gia-endoflebies-t... |
| therapeftis.eu (health-news blog, secondary source) EOF: enesima peptidia - injectable peptides, peptide therapy, kindynoi | August 2026 | www.therapeftis.eu/2026/08/eof-enesima-peptidia-injectable... |
| topontiki.gr I gkriza agora ton influencers sta social media proothoun epikindina peptidia gia adinatisma, afxisi mion | May 2026 | www.topontiki.gr/2026/05/29/i-gkriza-agora-ton-influencers... |
Links go to the issuing body wherever one exists. Positions change. If you are relying on any of this, check the source rather than this page.
Market brief
Take the Greece brief as a PDF
The regime, the buyer obligations and all 4 sources, dated and linked, in one document you can forward.
Nearby
Southern Europe and nearby markets
Buyers supplying one of these usually supply the others. The requirements are not the same.
| Code | Market | Sources | |
|---|---|---|---|
| FR | France | 3 sources | ANSM names compounds individually in its public alerts and has issued sanitary... |
| IT | Italy | 1 sources | AIFA regulates under the Codice del farmaco and has warned on illegal GLP-1 su... |
| ES | Spain | 2 sources | AEMPS has issued a formal notice on illegal GLP-1 supply and directs buyers to... |
| PT | Portugal | 5 sources | INFARMED governs medicines under the Estatuto do Medicamento and has flagged a... |
| IE | Ireland | 2 sources | The HPRA detained 763,027 dosage units of falsified or unauthorised medicines ... |
| LT | Lithuania | 4 sources | The VVKT regulates under the Farmacijos istatymas and requires a wholesale dis... |
Scope
How to use this page
A summary of the published regulatory position in Greece as at 2026-08-20, written for procurement teams deciding how to source. Every source is dated and linked so it can be checked at origin.
It is not legal advice. Full terms of supply, including where responsibility sits, are set out in our terms of supply.
Questions
Supplying into Greece
Do you supply into Greece?
We supply businesses that hold the authorisations their activity requires. Whether a specific compound can be supplied into Greece depends on that compound and on your authorisations, and we confirm it per compound at the enquiry stage.
Who carries the compliance obligation?
The importer of record and the party placing the product on the market, which is the buyer. We supply the batch documentation that supports your file. We cannot hold your authorisations for you.
How current is this page?
It was reviewed on 2026-08-20 and is scheduled for review again on 2026-11-18. Every source is dated and linked, so you can check the original.
We already supply into Greece. What changes if we source from you?
The batch documentation. You receive a Certificate of Analysis per batch, which can be issued under your own brand. The import and market-placing responsibilities stay where they are.
Is this legal advice?
No. It is a summary of the regulatory positions those authorities have published, as at the review date above. Take advice in your own market before you rely on it.
Enquire about supply into Greece
Tell us the compounds and your authorisations. We confirm per compound before anything ships.